Notice of Intent To Grant an Exclusive Patent License, 14924-14925 [2019-07287]

Download as PDF jbell on DSK30RV082PROD with NOTICES 14924 Federal Register / Vol. 84, No. 71 / Friday, April 12, 2019 / Notices discipline, social climate, athletics, diversity, curriculum and other matters relating to the USAFA. Agenda: 0730–0800 Arrive at Polaris Hall 0800–0805 Introductions & opening remarks by Designated Federal Officer 0805–0815 Call to Order, Agenda Overview, and Opening Comments BoV Chairman: Gen (Ret) Rice 0815–0845 Superintendent’s Update 0845–0900 Comfort Break 0900–0940 Commandant’s Update 0940–1020 Dean’s Update 1020–1030 Athletic Director Update 1030–1130 SAPR Office Update 1130–1215 BREAK: Group Photo, Lunch served 1215–1315 Discuss Report on National Discussion on Sexual Assault and Sexual Harassment at Colleges 1315–1330 Comfort Break/Admin Time 1330–1345 New Action Item Review 1345–1400 Superintendent’s Closing Remarks 1400–1430 Public Comment (DFO) 1430–1530 Board Discussion 1530–1545 Chairman’s Concluding Remarks/Adjourn End of Board of Visitors Meeting Meeting Accessibility: Open to the public subject to the availability of space. Registration of members of the public who wish to attend the meeting will begin upon publication of this meeting notice and end three business days (26 April) prior to the start of the meeting. All members of the public must contact Lt Col Caltagirone at the phone number or email listed below in the section titled FOR FURTHER INFORMATION CONTACT. Seating is limited and is on a first-to-arrive basis. Attendees will be asked to provide their name, title, affiliation, and contact information to include email address and daytime telephone number to the point of contact (POC) listed in the FOR FURTHER INFORMATION CONTACT section. Any interested person may attend the meeting, file written comments or statements with the committee, or make verbal comments from the floor during the public meeting, at the times, and in the manner, permitted by the BoV. Written Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140 and section 10(a)(3) of the FACA, the public or interested organizations may submit written comments or statements to the BoV about its mission and/or the topics to be addressed in this public meeting. Written comments or statements should be submitted to the BoV Executive Secretary, Lt Col Caltagirone, via electronic mail, the preferred mode of VerDate Sep<11>2014 18:18 Apr 11, 2019 Jkt 247001 submission, at the email address listed in the FOR FURTHER INFORMATION CONTACT section in the following formats: Adobe Acrobat or Microsoft Word. The comment or statement must include the author’s name, title, affiliation, address, and daytime telephone number. Written comments or statements being submitted in response to the agenda set forth in this notice must be received by the BoV Executive Secretary at least five (5) business days (24 April) prior to the meeting so that they may be made available to the BoV Chairman for their consideration prior to the meeting. Written comments or statements received after this date (24 April) may not be provided to the BoV until its next meeting. Please note that because the BoV operates under the provisions of the FACA, as amended, all written comments will be treated as public documents and will be made available for public inspection. Verbal Comments: Members of the public will be permitted to make verbal comments during the meeting only at the time and in the manner allowed herein. If a member of the public is interested in making a verbal comment at the open meeting, that individual must submit a request, with a brief statement of the subject matter to be addressed by the comment, at least three (3) business days (26 April) in advance, via electronic mail, the preferred mode of submission, at the email address listed in the FOR FURTHER INFORMATION CONTACT section. The BoV DFO will log each request to make a comment, in the order received, and the DFO and BoV Chairman will determine whether the subject matter of each comment is relevant to the BoV’s mission and/or the topics to be addressed in this public meeting. A period near the end of the meeting will be available for verbal public comments. Members of the public who have requested to make a verbal comment and whose comments have been deemed relevant under the process described in this paragraph, will be allotted no more than five (5) minutes during this period, and will be invited to speak in the order in which their requests were received by the DFO. For the benefit of the public, rosters that list the names of BoV members and any releasable materials presented during the BoV meeting shall be made available upon request. FOR FURTHER INFORMATION CONTACT: Lieutenant Colonel Angela Caltagirone, Directorate of Force Management Policy, BoV Executive Secretary, AF/A1PT, 1040 Air Force Pentagon, Washington, PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 DC 20330, (703) 692–4572, angela.k.caltagirone.mil@mail.mil. Carlinda N. Lotson, Federal Register Liaison Officer, Department of Defense. [FR Doc. 2019–07226 Filed 4–11–19; 8:45 am] BILLING CODE 5001–10–P DEPARTMENT OF DEFENSE Department of the Air Force [A59–190104A–JA] Notice of Intent To Grant an Exclusive Patent License Department of Defense, Department of the Air Force. ACTION: Notice of intent. AGENCY: Pursuant to the Bayh-Dole Act and implementing regulations, the Department of the Air Force hereby gives notice of its intent to grant an exclusive patent license agreement to University of California, San Diego, having a place of business at 9500 Gilman Drive, La Jolla, California 92093–0910. DATES: Written objections must be filed no later than fifteen (15) calendar days after the date of publication of this Notice. ADDRESSES: Submit written objections to the Air Force Materiel Command Law Office, AFMCLO/JAZ, 2240 B Street, Room 260, Wright-Patterson AFB, OH 45433–7109; Facsimile: (937) 255–3733; or Email: afmclo.jaz.tech@us.af.mil. Include Docket No. A59–190104A–JA in the subject line of the message. FOR FURTHER INFORMATION CONTACT: Air Force Materiel Command Law Office, Chastity D.S. Whitaker, AFMCLO/JAZ, 2240 B Street, Rm. 260, WrightPatterson AFB, OH 45433–7109; Facsimile: (937) 255–3733; Email: afmclo.jaz.tech@us.af.mil. SUPPLEMENTARY INFORMATION: The Department of the Air Force intends to grant the exclusive patent license agreement for the invention described in: —U.S. Patent No. 9,534,007, entitled, ‘‘METHODS AND COMPOSITION FOR TREATMENT OF CYANIDE AND HYDROGEN SULFIDE TOXICITY,’’ and issued 3 January 2017. The Department of the Air Force may grant the prospective license unless a timely objection is received that sufficiently shows the grant of the license would be inconsistent with the Bayh-Dole Act or implementing regulations. A competing application for SUMMARY: E:\FR\FM\12APN1.SGM 12APN1 Federal Register / Vol. 84, No. 71 / Friday, April 12, 2019 / Notices a patent license agreement, completed in compliance with 37 CFR 404.8 and received by the Air Force within the period for timely objections, will be treated as an objection and may be considered as an alternative to the proposed license. Authority: 35 U.S.C. 209; 37 CFR 404. BILLING CODE 5001–10–P DEPARTMENT OF DEFENSE Intent To Grant an Exclusive License for U.S. Government-Owned Invention Department of the Army, DoD. Notice. In accordance with applicable laws and regulations, announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable biological materials license. SUMMARY: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Director, Office of Research and Technology Applications, 1520 Freedman Drive, Suite 227, Fort Detrick, MD 21702–5012. ADDRESSES: Mr. Paul Michaels, Office of Research & Technology Applications, (301) 619– 4145. FOR FURTHER INFORMATION CONTACT: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i), announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable biological materials license to topical paromomycin formulation for the treatment of Leishmaniasis, to Appili Therapeutics, Inc., having its principal place of business at #21–1344 Summer Street, Halifax, NS B3H0A8, Canada. Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Director, Office of Research and Technology Applications (see ADDRESSES). jbell on DSK30RV082PROD with NOTICES Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2019–07294 Filed 4–11–19; 8:45 am] BILLING CODE 5001–03–P VerDate Sep<11>2014 18:18 Apr 11, 2019 Jkt 247001 Joint Rules of Appellate Procedure for Courts of Criminal Appeals DoD updated the JRAP, which prescribe uniform procedures for the service Courts of Criminal Appeals. The changes implement the Military Justice Act of 2016 of the National Defense Authorization Act of 2017 and the 2018 Amendments to the Manual for CourtsMartial, United States. The approval authorities for these changes are the Judge Advocates General of the Army, Department of the Navy, Air Force, and Coast Guard. DATES: The JRAP updates are effective January 1, 2019. FOR FURTHER INFORMATION CONTACT: Ms. Sarah Valdez, Clerk of the Court, United States Coast Guard Court of Criminal Appeals, (202) 795–6906, sarah.p.valdes@uscg.mil. SUPPLEMENTARY INFORMATION: The Department of Defense published a notice of availability of proposed changes to the Joint Rules of Appellate Procedure for Courts of Criminal Appeals on April 17, 2018 (83 FR 16841) for a 30-day public comment period. No public comments were received. The revisions to the JRAP are substantial and need to be read in their entirety. The JRAP revisions are available electronically at the Federal eRulemaking Portal at http:// www.regulations.gov within Docket ID: DOD–2018–OS–0019. A summary of the most significant changes to the Joint Rules of Appellate Procedure are as follows: SUMMARY: Department of the Army SUPPLEMENTARY INFORMATION: [Docket ID: DOD–2018–OS–0019] Joint Rules of Appellate Procedure for Courts of Criminal Appeals Committee, Department of Defense. ACTION: Notice of availability of final changes to the Joint Rules of Appellate Procedure for Courts of Criminal Appeals (JRAP). [FR Doc. 2019–07287 Filed 4–11–19; 8:45 am] ACTION: Office of the Secretary AGENCY: Carlinda N. Lotson, Acting Air Force Federal Register Liaison Officer. AGENCY: DEPARTMENT OF DEFENSE Rule 5—Jurisdiction Currently, appellants are entitled to an appeal as of right in cases in which the approved sentence extends to death, a punitive discharge, or confinement for a year or more. The Military Justice Act of 2016 of the National Defense Authorization Act of 2017 (MJA ’16) changes provide for automatic review in cases where confinement of two years or more is approved instead of one. Additionally, if an appellant affirmatively requests review, Court of PO 00000 Frm 00015 Fmt 4703 Sfmt 4703 14925 Criminal Appeals (CCA) now have jurisdiction in cases in which the appellant received an approved sentence of over six months, cases in which the United States has filed an appeal under Article 62 or 56(d) UCMJ. The new rule conforms to this new jurisdiction. The new Rule 5 also conforms to the changes in jurisdiction noted below, including appeals of sentences by the United States and the review of contempt findings by military judges and magistrates. Rule 20—Appeals by the United States, Including the Appeal of Sentences MJA ’16 provides for the United Sates to appeal sentences to the CCAs on the basis that the sentence violates the law or is plainly unreasonable. The new Rule 20 (formerly Rule 21) provides for the filing of such an appeal within 60 days of the entry of judgment. Rule 22—Briefs by Amicus Curiae This is a new rule not responsive to an MJA ’16 provision and addresses a subject not previously addressed in the joint rules, though service court rules have permitted amici. The new rule permits amici to file briefs by invitation of the court or my motion for leave to file. Unless the movant is a victim of an offense, potential amici must state whether the parties have consented to the filing. Rule 28—Contempt This is an entirely new rule necessitated by MJA ’16 changes. CCAs may now review contempt findings made by military judges and magistrates. The new rule provides a procedure for this review. Rule 29—Article 66(f) Proceedings This is an entirely new rule necessitated by MJA ’16 changes creating Art. 66(f)(3)(‘‘Additional Proceedings’’) and RCM 810, which effectively codify and expand DuBay. The rule mimics FRAP language, specifies that the Court retains jurisdiction when it orders a remand unless it explicitly dismisses the appellate proceedings, and it provides procedural guidance for hearings. This notice is intended only to improve the internal management of the Federal Government. It is not intended to create any right or benefit, substantive or procedural, enforceable at law by any party against the United States, its agencies, its officers, or any person. E:\FR\FM\12APN1.SGM 12APN1

Agencies

[Federal Register Volume 84, Number 71 (Friday, April 12, 2019)]
[Notices]
[Pages 14924-14925]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07287]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Air Force

[A59-190104A-JA]


Notice of Intent To Grant an Exclusive Patent License

AGENCY: Department of Defense, Department of the Air Force.

ACTION: Notice of intent.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Bayh-Dole Act and implementing regulations, 
the Department of the Air Force hereby gives notice of its intent to 
grant an exclusive patent license agreement to University of 
California, San Diego, having a place of business at 9500 Gilman Drive, 
La Jolla, California 92093-0910.

DATES: Written objections must be filed no later than fifteen (15) 
calendar days after the date of publication of this Notice.

ADDRESSES: Submit written objections to the Air Force Materiel Command 
Law Office, AFMCLO/JAZ, 2240 B Street, Room 260, Wright-Patterson AFB, 
OH 45433-7109; Facsimile: (937) 255-3733; or Email: 
[email protected]. Include Docket No. A59-190104A-JA in the 
subject line of the message.

FOR FURTHER INFORMATION CONTACT: Air Force Materiel Command Law Office, 
Chastity D.S. Whitaker, AFMCLO/JAZ, 2240 B Street, Rm. 260, Wright-
Patterson AFB, OH 45433-7109; Facsimile: (937) 255-3733; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: The Department of the Air Force intends to 
grant the exclusive patent license agreement for the invention 
described in:

--U.S. Patent No. 9,534,007, entitled, ``METHODS AND COMPOSITION FOR 
TREATMENT OF CYANIDE AND HYDROGEN SULFIDE TOXICITY,'' and issued 3 
January 2017.

    The Department of the Air Force may grant the prospective license 
unless a timely objection is received that sufficiently shows the grant 
of the license would be inconsistent with the Bayh-Dole Act or 
implementing regulations. A competing application for

[[Page 14925]]

a patent license agreement, completed in compliance with 37 CFR 404.8 
and received by the Air Force within the period for timely objections, 
will be treated as an objection and may be considered as an alternative 
to the proposed license.

    Authority:  35 U.S.C. 209; 37 CFR 404.

Carlinda N. Lotson,
Acting Air Force Federal Register Liaison Officer.
[FR Doc. 2019-07287 Filed 4-11-19; 8:45 am]
 BILLING CODE 5001-10-P